Predictors of efficacy in patients with HR positive/HER2 negative ABC: Subgroup analyses of PALOMA-3

Highlights from EBCC-12

Overview of the MINDACT trial results presented at EBCC-12

EBCC-12 during COVID-19

Why don’t all European breast cancer patients get the most appropriate care?

The management of endocrine therapy in young patients with breast cancer

Fatigue among long-term breast cancer survivors: a controlled cross-sectional study

Determinants of non-participation in population-based breast cancer screening: a systematic review and meta-analysis

Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer

Actionable pathogenic variant detection in breast cancer genes

Prediction of hot flushes in women taking tamoxifen for breast cancer prevention

The impact of COVID-19 on breast cancer screening, treatment, research and meetings

Improved decision making for older women with early breast cancer

MINDACT: 70-gene signature test as guidance for breast cancer treatment